CD8A and cancer: Further in vivo studies will be necessary to test the effectiveness of PCI vaccination with further cancer-related antigens and tumor neoantigens, as well as to investigate functionality of CD8+ CTLs in more detail, for example, by analyzing the effect on lysis of tumor cells.